Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

The Lancet - Tập 372 - Trang 449-456 - 2008
Robert J Motzer1, Bernard Escudier2, Stéphane Oudard3, Thomas E Hutson4, Camillo Porta5, Sergio Bracarda6, Viktor Grünwald7, John A Thompson8, Robert A Figlin9, Norbert Hollaender10, Gladys Urbanowitz10, William J Berg10, Andrea Kay10, David Lebwohl10, Alain Ravaud11
1Memorial Sloan Kettering Cancer Center, New York, NY, USA
2Institut Gustave Roussy, Villejuif, France
3Hôpital Européen Georges Pompidou, Paris, France
4US Oncology/Baylor-Sammons Cancer Center, Dallas, TX, USA
5IRCCS San Matteo University Hospital Foundation, Pavia, Italy
6Azienda Ospedaliera, Perugia, Italy
7Medical School Hannover, Hannover, Germany
8Cancer Care Alliance, Seattle, WA, USA
9City of Hope National Medical Center, Duarte, CA, USA
10Novartis Oncology, Florham Park, NJ, USA
11Hôpital Saint André CHU, Bordeaux, France

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

The Lancet

Tập 372

449-456

Thông tin tác giả